Xipei Wang
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Antibiotics Pharmacokinetics and Efficacy 7
- Pharmacogenetics and Drug Metabolism 3
-
- Blood Pressure and Hypertension Studies 4
- Antiplatelet Therapy and Cardiovascular Diseases 3
- Co-authors
- Zhi‐Xin Shan (4 shared papers)Jindong Xu (2 shared papers)Ni Zeng (2 shared papers)Jie-Ning Zhu (2 shared papers)Jinzhu Duan (2 shared papers)Sheng Wang (1 shared paper)Shujing Yuan (1 shared paper)Zhenzhen Yang (1 shared paper)
In The Last Decade
Xipei Wang
34 papers receiving 594 citations
Peers
Comparison fields: 5 of 111
- Cancer Research 168
- Applied Microbiology and Biotechnology 12
- Pharmacology 98
- Molecular Medicine 23
- Analytical Chemistry 42
Countries citing papers authored by Xipei Wang
This map shows the geographic impact of Xipei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xipei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xipei Wang more than expected).
Fields of papers citing papers by Xipei Wang
This network shows the impact of papers produced by Xipei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xipei Wang. The network helps show where Xipei Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xipei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 204 | |
| 2 | 2020 | 41 | |
| 3 | 2021 | 27 | |
| 4 | 2012 | 27 | |
| 5 | 2021 | 23 | |
| 6 | 2016 | 19 | |
| 7 | 2012 | 19 | |
| 8 | 2023 | 18 | |
| 9 | 2011 | 18 | |
| 10 | 2022 | 17 | |
| 11 | 2013 | 17 | |
| 12 | 2022 | 16 | |
| 13 | 2019 | 16 | |
| 14 | 2013 | 15 | |
| 15 | 2012 | 14 | |
| 16 | 2019 | 12 | |
| 17 | 2017 | 12 | |
| 18 | 2018 | 10 | |
| 19 | 2022 | 8 | |
| 20 | 2021 | 8 |
About Xipei Wang
Xipei Wang is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine, Psychiatry and Mental health, Infectious Diseases and Analytical Chemistry, having authored 35 papers that have together received 599 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (7 papers), Analytical Methods in Pharmaceuticals (6 papers), Blood Pressure and Hypertension Studies (4 papers), Antibiotic Resistance in Bacteria (4 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Schizophrenia research and treatment (3 papers) and Epilepsy research and treatment (3 papers). The work is most often cited by research in Cancer Research (168 citations), Applied Microbiology and Biotechnology (12 citations), Pharmacology (98 citations), Molecular Medicine (23 citations) and Analytical Chemistry (42 citations). Xipei Wang has collaborated with scholars based in China, Sweden and Canada. Frequent co-authors include Zhi‐Xin Shan, Jindong Xu, Ni Zeng, Jie-Ning Zhu, Jinzhu Duan, Sheng Wang, Shujing Yuan, Zhenzhen Yang, Rong Pan and Shulin Wu. Their work appears in journals such as Frontiers in Pharmacology, Journal of Pharmaceutical Sciences, Drug Design Development and Therapy, Journal of Chromatography B and Blood Purification.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.